missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CXCL10/IP-10/CRG-2 Antibody, R&D Systems™
Mouse Monoclonal Antibody
Marca: R&D Systems MAB266-500
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
CXCL10/IP-10/CRG-2 Monoclonal specifically detects CXCL10/IP-10/CRG-2 in Human samples. It is validated for Neutralization, Intracellular Staining by Flow Cytometry, CyTOF-ready, ELISA Capture (Matched Antibody Pair).
Especificaciones
CXCL10/IP-10/CRG-2 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
C7, chemokine (C-X-C motif) ligand 10, crg-2, CRG2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10 | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
3627 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot, Neutralization, Flow Cytometry, CyTOF, ELISA | |
33036 | |
Western Blot 1 ug/mL, Neutralization 0.5-2.0 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
P02778.2 | |
CXCL10 | |
E. coli-derived recombinant human CXCL10/IP-10/CRG-2 Val22-Pro98 Accession # P02778.2 | |
500 μg | |
Primary | |
Detects human CXCL10/IP-10/CRG-2 in ELISAs and Western blots. In Western blots, does not cross-react with recombinant human CXCL1, 2, 3, 5, 8, 9, 12/SDF-1 beta , recombinant mouse CXCL1, or 2. | |
Human | |
Ascites |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Human CXCL10/IP-10/CRG-2 Antibody, R&D Systems™ > 500μg; Unlabeled
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido